2-241744797-C-T
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong
The NM_152783.5(D2HGDH):c.773C>T(p.Ser258Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000229 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000024   (  0   hom.  ) 
Consequence
 D2HGDH
NM_152783.5 missense
NM_152783.5 missense
Scores
 13
 4
 2
Clinical Significance
Conservation
 PhyloP100:  5.57  
Publications
1 publications found 
Genes affected
 D2HGDH  (HGNC:28358):  (D-2-hydroxyglutarate dehydrogenase) This gene encodes D-2hydroxyglutarate dehydrogenase, a mitochondrial enzyme belonging to the FAD-binding oxidoreductase/transferase type 4 family. This enzyme, which is most active in liver and kidney but also active in heart and brain, converts D-2-hydroxyglutarate to 2-ketoglutarate. Mutations in this gene are present in D-2-hydroxyglutaric aciduria, a rare recessive neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. [provided by RefSeq, Jul 2008] 
D2HGDH Gene-Disease associations (from GenCC):
- D-2-hydroxyglutaric aciduria 1Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
 - D-2-hydroxyglutaric aciduriaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.954
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000132  AC: 2AN: 152090Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
152090
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000199  AC: 5AN: 251492 AF XY:  0.0000368   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
251492
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000239  AC: 35AN: 1461886Hom.:  0  Cov.: 34 AF XY:  0.0000206  AC XY: 15AN XY: 727246 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
35
AN: 
1461886
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
15
AN XY: 
727246
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33476
American (AMR) 
 AF: 
AC: 
0
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
31
AN: 
1112008
Other (OTH) 
 AF: 
AC: 
1
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 3 
 6 
 9 
 12 
 15 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000132  AC: 2AN: 152090Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74296 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152090
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74296
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41396
American (AMR) 
 AF: 
AC: 
0
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
67994
Other (OTH) 
 AF: 
AC: 
0
AN: 
2086
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
4
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not specified    Uncertain:1 
Oct 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Pathogenic 
 DEOGEN2 
 Benign 
T;. 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Pathogenic 
D;D 
 M_CAP 
 Pathogenic 
D 
 MetaRNN 
 Pathogenic 
D;D 
 MetaSVM 
 Pathogenic 
D 
 MutationAssessor 
 Pathogenic 
H;. 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Pathogenic 
D;D 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D;D 
 Sift4G 
 Uncertain 
D;D 
 Polyphen 
D;. 
 Vest4 
 MutPred 
Loss of relative solvent accessibility (P = 0.0676);.;
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.